BP000123-CYT-140: Recombinant Canine Tumor Necrosis Factor-Alpha (TNFα) Protein
Source: E. coli-derived.
The Specific Activity is >3.3?05 IU/mg as determined by the cytolysis of murine L929 cells in the presence of Actinomycin D.
Purity: > 95.0% by RP-HPLC and SDS-PAGE.BP000123-CYT-384: Recombinant Human Tumor Necrosis Factor α Mutant
Source: E. coli-derived.
The ED50 as determined by the cytolysis of murine L929 cells in the presence of Actinomycin D is < 0.05 ng/ml, corresponding to a Specific Activity of 20,000,000 units/mg.
Purity: > 95.0% by RP-HPLC and SDS-PAGE.BP000123-GD22: Recombinant Human Tumor Necrosis Factor alpha (TNFα) Protein
Source: E. coli-derived.
The ED50 as determined by the cytolysis of murine L929 cells in the presence of Actinomycin D is less than 0.03 ng/ml. Specific Activity of 3.0 x 10^7 IU/mg.
Purity: > 95% by SEC-HPLC and reducing SDS-PAGE.
Endotoxin: < 0.1 ng/ug (1 EU/ug).BP003077: Recombinant Human SIRP alpha V8 Protein
Source: mammalian cells.
Purity: > 95% by Bis-Tris PAGE and HPLC.BP003080: Recombinant Human LILRB4 / CD85k / ILT3 Protein
Source: mammalian cells.
Purity: > 95% by Bis-Tris PAGE and HPLC.C071P: Sacituzumab Biosimilar, Human Trop-2 Monoclonal Antibody
Recombinant Humanized IgG1 Monoclonal Antibody.
Specificity/Sensitivity: The monoclonal antibody sacituzumab biosimilar specifically binds to the human Trop-2 protein.
Applications: ELISA, neutralization, functional assays such as bioanalytical PK and ADA assays, and those assays for studying biological pathways affected by sacituzumab.C070P: Zolbetuximab Biosimilar, Claudin 18.2 Monoclonal Antibody
Recombinant Humanized IgG1 Monoclonal Antibody.
Specificity/Sensitivity: The in vivo grade zolbetuximab biosimilar specifically binds to the human Claudin 18.2 protein.
Applications: ELISA, neutralization, functional assays such as bioanalytical PK and ADA assays, and those assays for studying biological pathways affected by zolbetuximab (IMAB-362).